Objective: There is a body of evidence that the aging immune system is linked to cancer.
Introduction
In recent years, colorectal cancer (CRC) has become the third most common cancer in the world and is one of the leading causes of cancer-related death [1] . In the past few decades, due to a large number of studies on the pathogenesis of CRC, the diagnostic test and treatment strategies have made significant progress, which has led to the improvement of CRC survival [2] .
Previous studies have found that there are several pathogenic factors of cancer, such as genome instability and mutation, intestinal flora imbalance and unreasonable diet [3] .
Immune destruction is also one of the important causes of cancer. Therefore, chronic inflammation is one of the hallmarks of cancer [3] , and CRC has long been known as one of the best examples of a tumor closely associated with chronic inflammation, which can be present from the earliest stages of tumor onset [4] . CRC arises following prolonged inflammation in the intestine, as in patients with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis [5] . Strikingly, CRC can be prevented or delayed by treatment with anti-inflammatory drugs [6, 7] , which suggests the involvement of inflammatory processes in tumor onset. Inflammatory reactions are often linked to microbial responses, and the intestinal tract is populated by a myriad of bacterial strains that commonly live in harmony with their host, yet any substantial shift in the bacterial population can have a considerable effect on inflammatory responses and contribute to tumor development.
In addition, age is a major risk factor for many cancers. There is a body of evidence that aging immune system is linked to cancer [8] [9] [10] . There is a growing interest in immunosenescence and how it may contribute to the increased risk of cancer onset with aging. For example, CD4 T cells, especially T follicular helper cells, are critical for the generation of a robust humoral response to an infection or vaccination [11] . There is evidence that the aged microenvironment contributes to the age-related functional defects of CD4 T cells in mice [12] , and the age-related impairment of the humoral response to influenza is associated with changes in antigen-specific T follicular helper cell responses [13] .
Here, we hypothesize that ubiquitination might play a key gatekeeper role in immune system aging and tumorigenesis in CRC. Ubiquitination, the covalent attachment of ubiquitin molecules to proteins, is emerging as a widely utilized mechanism for rapidly regulating cell signaling. Recent studies indicate that ubiquitination plays potent roles in regulating a variety of signals in both innate and adaptive immune cells [14, 15] . A good example is that PD-1 ubiquitination could regulate the antitumor immunity of T cells. Dysfunctional T cells in the tumor microenvironment have an abnormally high expression of PD-1, and antibody inhibitors against PD-1 or its ligand (PD-L1) have become commonly used drugs to treat various types of cancer. A study showed that surface PD-1 undergoes internalization, subsequent ubiquitination and proteasome degradation in activated T cells [16] .
The study of tumor immune interactions presents great technical challenges due to the great heterogeneity in the tumor microenvironment and global immune system function.
Blood cell DNA methylome analysis provides a promising tool to probe the key components of immune cell dysregulation in aging and tumorigenesis. Several DNA methylation markers for the quantification of tumor immune cell infiltrates have been discovered, and their improved specificity over other markers has already been demonstrated. For example, DNA methylation of FOXP3 allows the distinction of T lymphocyte subpopulations such as regulatory T cells from other types of T lymphocytes. These subpopulations are difficult to distinguish by other methods (gene expression or immunohistochemistry) because they express the same surface markers [17, 18] . The power of DNA methylation as a tool for cell typing has further been underpinned by the development of DNA methylation signatures that allow the simultaneous quantification of different immune cell populations in blood. There are reports that a broad signature for hepatocellular carcinoma (HCC) in peripheral blood mononuclear cell and T cell DNA methylation, which discriminates early HCC stage from chronic hepatitis B and C and healthy controls, intensifies with the progression of HCC [19] .
In the present study, we will systematically study the DNA methylation of ubiquitination regulatory system genes in blood cells and screen candidate genes that are correlated with both aging and immune cell compositions. Then, we will use lowcost nucleic acid mass spectrometry (Sequenom) to test whether ubiquitination genes can be used as candidate markers for the early screening of CRC.
Materials and Methods

Identification of differential genes associated with aging and immune cell proportions
In our study, aging-related (GSE40279) and immune-related (GSE69270) DNA methylation data were collected from the GEO database (www.ncbi.nlm.nih.gov/geo).
GEO is an open-source functional genomics database of high-throughput resources, including microarray data, gene expression data, and DNA methylation data. The probes are transformed into the homologous gene symbol by means of the platform's annotation information. The GSE40279 dataset contained DNA methylation profiles across approximately 450K CpGs in the human whole blood of 656 samples from patients whose age ranged from 19 to 101 years. The GSE69270 dataset contained DNA methylation profiles in the whole blood of 184 samples with annotations of six immune cell proportions, including CD8 T and CD4 T cells, monocytes, granulocytes, and NK and B cells. Next, we calculated the differential genes during aging and their association with immune cell proportion in the circulating whole blood of healthy individuals.
Recently, a study published in Genome Res. found that there is a strong relationship between the methylation of gene body difference to promoter (MeGDP) and gene expression, and the correlation coefficient is as high as 0.67 [20] . Therefore, MeGDP can be used as a predictor of gene expression. The higher the MeGDP is, the higher the expression value of a gene, suggesting that the degree of association with the relevant phenotype is higher. Based on the results of the above research, our other paper proposes the Statistical Difference of DNA Methylation between Promoter and other regions (SimPo) to calculate the DNA methylation characteristics of different genes (Figure 1 ) [21] .
The input data of the SimPo algorithm is the DNA methylation value of cg probes that are located in the gene promoter and the other regions. The significant difference method T-test is used in the SimPo algorithm, and the degree of difference (SimPo score) is used to characterize the DNA methylation of corresponding genes as follows [21] :
x ̅: average DNA methylation value of all probes that are located in the promoter region; y ̅: average DNA methylation value of all probes that are located in the other region; m: number of probes that are located in the promoter region; n: number of probes that are located in the other region; S 1 2 : variance of DNA methylation values of probes that are located in the promoter region; and S 2 2 : variance of DNA methylation values of probes that are located in the other region. In addition, since the SimPo score relates to the number of probes, to ensure the reliability of the SimPo score, we only selected genes with a number of promoter region-located and other region-located probes greater than or equal to five for further calculation.
Based on the SimPo algorithm, this study separately calculated the SimPo scores of each gene in the aging-related DNA methylation data and immune cell proportionrelated DNA methylation data. Next, we calculated the differences in gene SimPo scores between the old age (> 50 year) and middle age (≤ 50 year) individuals based on the adjusted T-test. Then, for the immune-related methylation data, we identified the differential genes that were significantly associated with immune cell proportion based on the adjusted Spearman correlation test.
Ubiquitination genes collection
In this study, we collected 233 reviewed E3 ubiquitin ligase genes in humans by querying the UniProt database (https://www.uniprot.org) with "E3 ubiquitin-protein ligase" as a key word (Figure 1 , Table S1 ).
Figure 1. Method pipeline of candidate marker validation and prediction model
construction for colorectal cancer.
The biological functions were enriched for 233 E3 ubiquitin ligases using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway records in the Database for
Annotation, Visualization and Integrated Discovery (DAVID, https://david.ncifcrf.gov/) [21] . The corresponding catalogs and diseases of the KEGG pathways were downloaded from the KEGG Pathway Database (https://www.genome.jp/kegg/pathway.html) [23] . The results showed that these E3 ubiquitin ligases were enriched in 4 KEGG pathways (Bonferroni-adjusted P-value ≤ 0.05), of which the most significant is the ubiquitin-mediated proteolysis pathway (Table S2 ). This result indicates that these 233 E3 ubiquitin ligases are significantly associated with ubiquitination and could be used for the next analysis.
Clinical blood samples collection
We analyzed blood samples from 100 diagnosed CRC patients (male: 67, female: 33)
from Guangdong Provincial People's Hospital and FoShan New RongQi Hospital. A total of 53% of the samples were diagnosed with pTNM stage I/II. We also collected 50 normal control samples (male: 18; female: 32) from FoShan New RongQi Hospital.
All peripheral whole blood cell samples were treated with EDTA anticoagulant.
MassARRAY analysis
We were generated by the EpiTyper v1.0.5 software (Supplementary Material).
Results
Biological analysis of aging and CD4 T cell proportion-derived differential genes
Based on the SimPo algorithm, we calculated the SimPo scores for each gene of the aging and immune-related DNA methylation data. In the aging-related methylation data, we identified a total of 2358 genes that were significantly associated with the age of the patient (based on the adjusted T-test). In the immune-related methylation data, we identified a total of 1331 genes that were significantly associated with the CD4 T cell proportion (based on the adjusted Spearman correlation test).
First, we performed KEGG pathway enrichment analyses of the above significant gene sets by using the Enrichr database (https://amp.pharm.mssm.edu/Enrichr/) [24] . The results showed that the aging-associated genes were enriched in 32 significant KEGG pathways, and the immune-associated genes were enriched in 23 significant KEGG pathways. Among them, it is worth noting that the cellular senescence pathway is enriched in both the aging-and immune-associated gene sets ( Table 1 ). In addition, the ubiquitin-mediated proteolysis pathway was identified by an immune-related gene set (Table 1) . Therefore, the results indicated that genes that are significantly disturbed in DNA methylation level during the aging and immunization processes are associated with ubiquitination. In addition, the Gene Ontology (GO) molecular function results further validate the above conclusion. The aging-derived differential genes were enriched in the ubiquitinlike protein ligase binding and ubiquitin protein ligase binding terms ( Table 2 ). CD4 T cell proportion-derived differential genes were also enriched in the ubiquitin binding term ( Table 2 ). The GO biological process results show that the aging-derived differential genes were enriched in the proteasome-mediated ubiquitin-dependent protein catabolic process and ubiquitin-dependent protein catabolic process terms ( Table 3) . The CD4 T cell proportion-derived differential genes were enriched in the positive regulation of the proteasomal ubiquitin-dependent protein catabolic process, the regulation of the proteasomal ubiquitin-dependent protein catabolic process and protein polyubiquitination ( Table 3) . Furthermore, we performed disease association analysis for the aging-and immunerelated gene sets. Starting from the disease-gene associations of the ClinVar database [24] , we found that the differential genes of aging were significantly associated with 12 diseases, and the differential genes of the immune system were significantly associated with 11 diseases. Interestingly, both are significantly associated with bowel cancerrelated diseases, including colon carcinoma, hereditary nephrotic syndrome, and familial colorectal cancer ( Table 4 ). These results indicated that aging and CD4 T cell proportion may play important roles in the development of colorectal cancer. 
E3 genes associated with aging
In the above results, we not only proved that the aging immune system is related to the onset of CRC but also further verified that ubiquitinated genes play an important role in the aging immune system. Therefore, we conducted further analyses on the 233 E3 genes. A total of 103 of the 233 E3 genes have cg probe annotations on the Illumina Infinium 450K Human Methylation Beadchip. Then, we obtained the SimPo scores of 42 E3 genes. The methylation SimPo scores of 23 E3 genes were significantly associated with the patient ages based on the adjusted T-test, and the E3 gene DZIP3 ranked sixth (Figure 2a and Figure 3a ) (Table S3 ). The E3 gene list that is significantly associated with CD4 T cell proportion (top 10).
(c) The intersecting genes that are significantly associated with both aging (top 10) and CD4 T cell proportion (top 10).
E3 genes associated with immune cell proportions
Then, we obtained the SimPo scores of 38 E3 genes based on the GSE69270 dataset.
We calculated the Pearson correlations between the SimPo scores of the 38 E3 ubiquitin ligases with immune cell proportions (including CD8 T and CD4 T cells, monocytes, granulocytes, and NK and B cells) and the sum of CD8 T and CD4 T cells. The Pearson correlation results showed that 15 E3 genes were significantly associated with the CD4 T cell proportion (Figure 2b and Table S4 ), including the E3 gene DZIP3 (Figure 3b) .
It is worth noting that there were two genes (UBR1 and DZIP3) that appeared in the top ten genes related to aging and CD4 T cell proportion (Figure 2c) 
Methylation variations in DZIP3 amplicon-cg14787155
The clinicopathological characteristics of CRC patients are shown in (Figure 4A, Table S5 ). 
Colorectal cancer prediction model based on amplicon-cg14787155
With EpiDesigner software, we obtained the sequence of the MassARRAY primer relative to the amplicon-cg14787155 region ( Table 6 ). Based on the effective detected methylation data of 15 methylation units, we constructed a prediction model to classify colorectal cancer patients from normal controls. As shown above, sex would be an important factor in predicting cancer state, and we also set sex as an input factor in the prediction model. sex showed the best performance (AUC = 0.833 and OR = 8.82) ( Figure 4B) .
Additionally, we constructed the all-stage colorectal cancer prediction model in the full data set. A model with the optimized input CpG sites (CpG_12, CpG_18, CpG_1.2, CpG_6, CpG_11, CpG_3.4) and sex showed the best performance (AUC = 0.782 and OR = 5.7) (Figure 4C) . The results showed that the methylation state of the amplicon-cg14787155 region has specific features in predicting early-stage and all-stage colorectal cancer. 
Discussion
Ubiquitination is one of the main types of covalent modification of intracellular proteins.
It participates in almost all life activities, such as cell survival, cell differentiation, and innate and acquired immunity [25] [26] [27] . The abnormalities of ubiquitination are closely related to the occurrence of various tumors [28] [29] [30] [31] [32] . It is worth noting that, consistent with the findings of this study, studies have shown that E3 ligase-mediated ubiquitination plays an important role in the development of CRC [33, 34] . In this study, starting with E3 ubiquitin ligase genes, we screened early markers of CRC related to immune system aging and immune escape. The results showed that the ubiquitination regulatory gene DZIP3 was significantly correlated with age and changes in immune cell components. Furthermore, we designed a low-cost nucleic acid mass spectrometry kit, which was validated by recruiting patients with early colorectal cancer. [35] . In recent years, peripheral blood circulating tumor cells (CTCs) have made great progress, and this technique is convenient for blood collection, with high public acceptance. However, there are still many problems in the application of CTCs. For example, positive results of CTCs still require confirmation by colonoscopy, and the appropriate testing interval of CTCs should be further explored.
However, this study used the DNA methylation characteristics of DZIP3 as early screening markers of early-stage CRC (sensitivity = 0.760, specificity = 0.774) and allstage CRC (sensitivity = 0.720, specificity = 0.720). In addition, this screening technique only needs to extract the whole blood of individuals for MassARRAY analysis; the samples are easy to obtain, and the results are objective. Therefore, this method may have important applications in clinical CRC screening.
Another interesting feature of the present study suggests a novel early cancer screening approach based on blood cells. This blood cell methylation analysis mainly reflects the status of the immune system rather than cancer cells. Traditionally, liquid biopsy is focused on DNA mutation or DNA methylation tests on circulating free DNAs, which are mainly released by cancerous cells. Our results confirmed that aging and immune escape are important links in the development of intestinal cancer. Considering that a certain frequency of gene mutations will occur in healthy people and healthy tissues, the speed-limiting step of cancer occurrence, that is, the bottleneck, is not gene mutation but changes in the immune system. As cancer cells and immune systems reflect the yinyang aspects of tumorigenesis, our results raise a new option for detecting the early and rate-limiting steps of tumorigenesis. Considering that blood cell methylation analysis could be conducted in healthy individuals, it is possible that our method could outline a continuous curve of healthy, inflammation, and transformation processes from enteritis to cancer. Thus, our method holds specific value for use in health management compared to the traditional liquid biopsy method, in which strong signals will appear only after enough cancer cells have been produced.
